HOME >> MEDICINE >> NEWS
Smallpox vaccine may cause harmless skin rashes

People who have never received a smallpox vaccination may develop any of a variety of benign skin rashes a few days after getting vaccinated for smallpox that should not be confused with a more serious complication of the vaccine, according to an article in the April 1 issue of Clinical Infectious Diseases, now available online.

Vaccinia is a virus used to immunize people against smallpox. The study examined 350 adult volunteers, 250 of whom were "vaccinia-nave," or had never been vaccinated for smallpox before, and 100 of whom were "vaccinia-experienced," or had previously received a smallpox vaccination. Of the vaccinia-nave, 3.6 percent developed some type of skin rash 6-19 days after being vaccinated. Symptoms usually included itching, redness and small bumps on the skin, and some patients also complained of headaches.

The five different types of rashes described in the article were all "self-limiting"--that is, they cleared up on their own after one to three weeks--and were not accompanied by fever or any other serious symptoms. The harmlessness of the vaccinia-associated skin rashes makes the findings important, according to Dr. Richard Greenberg, lead author of the study, which took place from July of 2002 to February of 2003.

"Physicians need to know that [the skin reactions] are benign and can be treated with medicines such as antihistamine," said Dr. Greenberg of the University of Kentucky School of Medicine. Doctors who realize that the rashes are not dangerous can offer reassurance to concerned patients and prescribe appropriate medications for symptom relief.

A physician who is unaware of the possibility for a benign skin reaction might wrongly assume that a patient's rash was the development of one of the more dangerous vaccinial lesions. "The concern is that the physician would overreact," Dr. Greenberg said. "These skin reactions are rather dramatic, and if we're going to be vaccinating against smallpox, the physicia
'"/>

Contact: Diana Olson
dolson@idsociety.org
703-299-0201
Infectious Diseases Society of America
17-Mar-2004


Page: 1 2

Related medicine news :

1. Smallpox vaccine can be diluted and still be effective, expanding supply if needed
2. Smallpox outbreak response: Targeted vaccination may be almost as effective as mass vaccination
3. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
4. NIAID initiates trial of experimental avian flu vaccine
5. Study finds majority of women willing to accept cervical cancer vaccine for self and children
6. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
7. Earlier use of prostate cancer vaccines urged by Hopkins scientists
8. Researchers close in on breast cancer vaccine
9. EuroVacc 02 HIV vaccine trial begins in February 2005
10. Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
11. Pathogen-mimicking vaccine as strategy for cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... British Columbia (PRWEB) , ... June 28, 2017 ... ... CNZCF) (FSE: ZEON) is pleased to announce that a two year study conducted ... the Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As ...
(Date:6/28/2017)... OH (PRWEB) , ... June 28, 2017 , ... ... of Hamilton County and the surrounding regions access to insurance assistance and financial ... with Matthew 25: Ministries to assist families in the region facing financial crisis. ...
(Date:6/28/2017)... Cincinnati, OH (PRWEB) , ... June 28, 2017 ... ... and financial consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is ... help provide temporary lodgings for families with children receiving treatment in nearby hospitals. ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 ... survey data released today by the American Society for Dermatologic Surgery ... the percentage of consumers considering a cosmetic medical procedure has doubled since 2013. ...
(Date:6/27/2017)... ... , ... Harbour , a DAO (decentralized autonomous organization) that harnesses the ... their technical specifications . , 2017 has seen an explosion of token launches ... which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of Harbour, ...
Breaking Medicine News(10 mins):
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/27/2017)... --  NuEyes (NuEyes Technologies Inc.) today announced that it ... in helping the legally blind live more independent lives. NuEyes works ... developer of augmented, virtual and mixed reality smartglasses and the ... funding amount was provided by strategic partners as well as ... Abu Dhabi , New York ...
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology:
Cached News: